Chad Langager is a co-founder of Second Summit Ventures. He started as an intern at Investopedia.com, eventually leaving for the startup scene. Samantha (Sam) Silberstein, CFP®, CSLP®, EA, is an ...

A CUSIP is a number assigned to a registered security such as a stock, bond, or mutual fund so that the security can be uniquely identified. The Committee on Uniform Securities Identification ...

Adam Hayes, Ph.D., CFA, is a financial writer with 15+ years Wall Street experience as a derivatives trader. Besides his extensive derivative trading expertise, Adam is an expert in economics and ...

The Federal Deposit Insurance Corporation board shocked the municipal bond market on Tuesday with a proposal that would switch out CUSIP numbers with Financial Instrument Global Identifiers, a marker ...

CUSIP numbers uniquely identify North American securities, facilitating faster trading. CUSIP numbers, started in 1964 due to trade clearance delays, are integral to U.S. securities. CUSIP identifiers ...

In May, a US broker-dealer received a letter from FactSet threatening to turn off its access to Cusips—nine-digit alphanumeric codes that uniquely identify nearly all North American stocks and bonds.

In May, Princeton University, a non-profit with access to the tax-exempt debt markets, chose to issue $300 million of taxable debt with a corporate CUSIP side-by-side with a traditional $300 million ...

Data licenses from Cusip Global Services (CGS)—and the things they do and do not permit—sit at the heart of an ongoing federal court case in the Southern District of New York. Recent witness testimony ...

View post: AT&T follows T-Mobile with bold move to win back customers View post: After Rate Cut, Fed Chair Jerome Powell Credits Automation and AI For Contributing to This "Structural" Boom in the U.S ...

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author. The CUSIP Entity Identifier (CEI), a unique 10-character code assigned to ...

NEW YORK--(BUSINESS WIRE)--OS Therapies (NYSE American: OSTX) (“OS Therapies” or “the Company”), an ADC and Immunotherapy research and clinical-stage biopharmaceutical company, today provided a ...

ROCHESTER, N.Y., Oct. 05, 2021 (GLOBE NEWSWIRE) -- DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating business ...